
    
      After liver resection to remove the hepatocellular carcinioma completely, the patients with
      high risk of tumor recurrence will be enrolled into this study. The high risk of tumor
      recurrence depends on tumor characteristics. The risk factors of tumor characteristics
      included tumor size >5 cm in diameter, abscence of encapsulation, vascular invasion and
      presence of daughter nodules. The patients with high risk of tumor recurrence will have 1 to
      3 risk factors. When the patients are enrolled into the study, oral thalidomide in
      combination with tegafur-uracil will be applied to prevent tumor recurrence. The patients
      will be fillowed uo erevy 3 mnoths.
    
  